![Sandoz Logo](/news-release/logo/360819/0/360819.jpg?lastModified=12%2F09%2F2016%2023%3A14%3A56&size=2)
Sandoz Canada launches PrSandoz(R) Duloxetine, a generic version of Cymbalta*, for the treatment of depression and anxiety symptoms
May 17, 2016 14:42 ET
|
Sandoz Canada
Click on this link to read the French version
BOUCHERVILLE, QC, May 17, 2016 (GLOBE NEWSWIRE) -- Sandoz Canada announced today that it has launched on the Canadian market PrSandoz®...
![Sandoz Logo](/news-release/logo/360819/0/360819.jpg?lastModified=12%2F09%2F2016%2023%3A14%3A56&size=2)
Sandoz Canada Inc. launches PrTOBRAMYCIN INHALATION SOLUTION, a generic version of PrTOBI indicated for pulmonary infections in cystic fibrosis patients
March 31, 2016 09:19 ET
|
Sandoz Canada
BOUCHERVILLE, QC, March 31, 2016 (GLOBE NEWSWIRE) -- Sandoz Canada Inc. announced the launch of PrTOBRAMYCIN INHALATION SOLUTION, an authorized generic version of PrTOBI*, currently marketed by...
![Logo Sandoz bleu HD_EN](http://www.globenewswire.com/en/Attachment/LogoDisplay/368781?filename=368781.png&size=2)
Sandoz Canada launches two easy-to-use products: Salinex(R) Seawater nasal spray for daily care and Ezeva(TM) zinc oxide cream
December 07, 2015 12:51 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Dec. 7, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of two easy-to-use products: Salinex® Seawater to help reduce...
![Sandoz Logo](/news-release/logo/360819/0/360819.jpg?lastModified=12%2F09%2F2016%2023%3A14%3A56&size=2)
Sandoz Canada Launches a New Concentration of (T/C)Lorazepam Injection USP
December 02, 2015 19:54 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of (T/C)Lorazepam Injection USP 2 mg/mL, a new concentration...
![SANDOZ_AN_bleu](http://www.globenewswire.com/en/Attachment/LogoDisplay/368301?filename=368301.png&size=2)
Sandoz Canada Launches a New Concentration of T/CLorazepam Injection USP
December 02, 2015 14:19 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of T/CLorazepam Injection USP 2 mg/mL, a new concentration now...
![Sandoz Logo](/news-release/logo/360819/0/360819.jpg?lastModified=12%2F09%2F2016%2023%3A14%3A56&size=2)
Sandoz Canada launches new multi-platform application to show real-time availability of its injectable medicines
October 14, 2015 13:28 ET
|
Sandoz Canada
Version française
BOUCHERVILLE, Quebec, Oct. 14, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada, which established a milestone in transparency by providing the first national report on availability...
![SANDOZ_AN_bleu](http://www.globenewswire.com/en/Attachment/LogoDisplay/360032?filename=360032.png&size=2)
Sandoz Canada launches PrSandoz(R) Solifenacin on the Canadian market for the treatment of urinary urgency, frequency and incontinence
October 07, 2015 16:41 ET
|
Sandoz Canada
Version française
BOUCHERVILLE, QC, Oct. 7, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of a new drug on the Canadian market, PrSandoz® Solifenacin (solifenacin...
![BenDesjardins2015_0016](http://www.globenewswire.com/en/Attachment/LogoDisplay/358482?filename=358482.png&size=2)
Sandoz Canada Celebrates Its 10th Anniversary!
September 25, 2015 09:15 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Sept. 25, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada Inc. celebrated its 10th anniversary on September 19 this year with a colourful event in...
![Sandoz Logo](/news-release/logo/360819/0/360819.jpg?lastModified=12%2F09%2F2016%2023%3A14%3A56&size=2)
Health Canada Approves New Indications for PrOmnitrope(R) (Somatropin), Canada's First Subsequent Entry Biologic (Biosimilar)
September 02, 2015 16:11 ET
|
Sandoz Canada
Click here for the French version.
BOUCHERVILLE, Quebec, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada Inc., a Novartis company, has received approval from Health Canada for a number of...
![Amiodarone_Syringe](http://www.globenewswire.com/en/Attachment/LogoDisplay/354083?filename=354083.png&size=2)
Sandoz Canada launches PrAmiodarone Syringe for the treatment of several heart rhythm disorders
August 20, 2015 16:42 ET
|
Sandoz Canada
BOUCHERVILLE, Quebec, Aug. 20, 2015 (GLOBE NEWSWIRE) -- Version française
Sandoz Canada Inc., a Novartis company, continues to innovate with the launch of PrAmiodarone Syringe (PrAmiodarone...